Literature DB >> 15692814

Seroprevalence of herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) in former East and West Germany, 1997-1998.

W Hellenbrand1, W Thierfelder, B Müller-Pebody, O Hamouda, T Breuer.   

Abstract

The aim of this study was to investigate the seroprevalence of herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) in representative samples of the total former East German (FEG) and total former West German (FWG) populations. Type-specific testing with the HSV-1 (gG1) and HSV-2 (gG2) indirect ELISA was performed on an age- and sex-stratified random subsample of 3,792 sera collected during the 1997-1998 German National Health Survey. Weighted seroprevalence estimates were calculated for the total FEG and FWG populations. The overall age-standardised seroprevalence of HSV-1 was 82.6% in Germany, 85.5% (95%CI, 83.4-87.3%) in FEG and 81.8% (95%CI, 79.9-83.6%) in FWG. The overall seroprevalence of HSV-2 was 13.3% (95%CI, 11.8-14.9) in Germany, 16.5% (95%CI, 14.1-18.9) in FEG and 12.6% (95%CI, 10.7-14.5%) in FWG. The difference between FEG and FWG was largely due to the significantly higher age-adjusted seroprevalence of HSV-1 and HSV-2 in women (but not men) in FEG as compared to FWG. The HSV seroprevalence estimates in this study are consistent with results of previous less representative seroprevalence studies in Germany. Differences in HSV-2 seroprevalence between FEG and FWG suggest differences in sexual behaviour that warrant further investigation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15692814     DOI: 10.1007/s10096-005-1286-x

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  19 in total

Review 1.  [Virology, epidemiology and diagnosis of herpes genitalis].

Authors:  J F Chenot; H F Rabenau; H W Doerr
Journal:  Dtsch Med Wochenschr       Date:  1999-02-12       Impact factor: 0.628

2.  Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis.

Authors:  Anna Wald; Katherine Link
Journal:  J Infect Dis       Date:  2001-12-14       Impact factor: 5.226

3.  A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group.

Authors:  A G Langenberg; L Corey; R L Ashley; W P Leong; S E Straus
Journal:  N Engl J Med       Date:  1999-11-04       Impact factor: 91.245

4.  Seroprevalence of herpes simplex virus types 1 and type 2 in the Frankfurt am Main area, Germany.

Authors:  H F Rabenau; S Buxbaum; W Preiser; B Weber; H W Doerr
Journal:  Med Microbiol Immunol       Date:  2002-03       Impact factor: 3.402

5.  Seroprevalence study of herpes simplex virus type 2 among pregnant women in Germany using a type-specific enzyme immunoassay.

Authors:  G Enders; B Risse; M Zauke; I Bolley; F Knotek
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-12       Impact factor: 3.267

6.  Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women.

Authors:  A Wald; A G Langenberg; K Link; A E Izu; R Ashley; T Warren; S Tyring; J M Douglas; L Corey
Journal:  JAMA       Date:  2001-06-27       Impact factor: 56.272

7.  Changing trends in genital herpes simplex virus infection in Bergen, Norway.

Authors:  A Nilsen; H Myrmel
Journal:  Acta Obstet Gynecol Scand       Date:  2000-08       Impact factor: 3.636

8.  [Laboratory tests in The Child and Adolescent Health Survey].

Authors:  W Thierfelder; K E Bergmann; W Hellenbrand; C Seher; A Tischer; W Thefeld
Journal:  Gesundheitswesen       Date:  2002-12

9.  The epidemiology of herpes simplex types 1 and 2 infection of the genital tract in Edinburgh 1978-1991.

Authors:  J D Ross; I W Smith; R A Elton
Journal:  Genitourin Med       Date:  1993-10

10.  The seroepidemiology of herpes simplex virus type 1 and 2 in Europe.

Authors:  R G Pebody; N Andrews; D Brown; R Gopal; H De Melker; G François; N Gatcheva; W Hellenbrand; S Jokinen; I Klavs; M Kojouharova; T Kortbeek; B Kriz; K Prosenc; K Roubalova; P Teocharov; W Thierfelder; M Valle; P Van Damme; R Vranckx
Journal:  Sex Transm Infect       Date:  2004-06       Impact factor: 3.519

View more
  9 in total

1.  Lack of association of herpesviruses with brain tumors.

Authors:  S Poltermann; B Schlehofer; K Steindorf; P Schnitzler; K Geletneky; J R Schlehofer
Journal:  J Neurovirol       Date:  2006-04       Impact factor: 2.643

Review 2.  [Sexually transmitted infections of the anorectal region].

Authors:  P Spornraft-Ragaller; U Boashie; S Esser
Journal:  Hautarzt       Date:  2015-06       Impact factor: 0.751

3.  Seroprevalence of parvovirus B19 in the German population.

Authors:  C Röhrer; B Gärtner; A Sauerbrei; S Böhm; B Hottenträger; U Raab; W Thierfelder; P Wutzler; S Modrow
Journal:  Epidemiol Infect       Date:  2008-01-16       Impact factor: 2.451

4.  Sexually transmitted infections in Pakistan.

Authors:  Muhammad Arif Maan; Fatma Hussain; Javed Iqbal; Shahid Javed Akhtar
Journal:  Ann Saudi Med       Date:  2011 May-Jun       Impact factor: 1.526

5.  Generation of “LYmph Node Derived Antibody Libraries” (LYNDAL) for selecting fully human antibody fragments with therapeutic potential.

Authors:  Philipp Diebolder; Armin Keller; Stephanie Haase; Anne Schlegelmilch; Jonathan D Kiefer; Tamana Karimi; Tobias Weber; Gerhard Moldenhauer; Roland Kehm; Anna M Eis-Hübinger; Dirk Jäger; Philippe A Federspil; Christel Herold-Mende; Gerhard Dyckhoff; Roland E Kontermann; Michaela A E Arndt; Jürgen Krauss
Journal:  MAbs       Date:  2014 Jan-Feb       Impact factor: 5.857

6.  Decreasing seroprevalence of herpes simplex virus type 1 and type 2 in Germany leaves many people susceptible to genital infection: time to raise awareness and enhance control.

Authors:  Gerit Korr; Michael Thamm; Irina Czogiel; Christina Poethko-Mueller; Viviane Bremer; Klaus Jansen
Journal:  BMC Infect Dis       Date:  2017-07-06       Impact factor: 3.090

7.  Application and tolerability of Herpotherm(®) in the treatment of genital herpes.

Authors:  Gerrit Schlippe; Werner Voss; Lars Christian Brenn
Journal:  Clin Cosmet Investig Dermatol       Date:  2013-06-05

8.  Increased seroprevalence of HAV and parvovirus B19 in children and of HEV in adults at diagnosis of autoimmune hepatitis.

Authors:  Richard Taubert; Jana Diestelhorst; Norman Junge; Martha M Kirstein; Sven Pischke; Arndt Vogel; Heike Bantel; Ulrich Baumann; Michael P Manns; Heiner Wedemeyer; Elmar Jaeckel
Journal:  Sci Rep       Date:  2018-11-28       Impact factor: 4.379

9.  Characteristics of neonatal herpes simplex virus infections in Germany: results of a 2-year prospective nationwide surveillance study.

Authors:  André Kidszun; Anna Bruns; Daniel Schreiner; Susanne Tippmann; Julia Winter; Roman M Pokora; Michael S Urschitz; Eva Mildenberger
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2021-07-13       Impact factor: 5.747

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.